- $34.20bn
- $20.60bn
- CNY134.60bn
- 96
- 85
- 51
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 107,413 | 107,074 | 124,493 | 123,675 | 134,598 |
Cost of Revenue | |||||
Gross Profit | 44,563 | 68,690 | 70,285 | 67,541 | 69,567 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 110,807 | 95,034 | 118,275 | 110,764 | 113,557 |
Operating Profit | -3,394 | 12,040 | 6,218 | 12,911 | 21,041 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -340 | 23,090 | 10,778 | 10,112 | 25,198 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,288 | 19,026 | 7,591 | 7,534 | 21,549 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,980 | 22,384 | 9,876 | 6,968 | 19,598 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,355 | 22,384 | 9,876 | 6,968 | 19,598 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.35 | 9.24 | 4.59 | 3.28 | 7.15 |